Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., Cleveland State University 2014
• Research
• 

  Selected Grants

  • Role of GLUD2 as a metabolic driver of gliomas with IDH1 mutations awarded by National Institutes of Health 2016 - 2021
• Publications & Artistic Works
• 

  Selected Publications

  • Book Sections

    • Waitkus, M, Harris, D, and DiCorleto, P. "Mechanisms of Endothelial Activation." . (Chapter)  Full Text

  • Journal Articles

    • Waitkus, MS, Diplas, BH, and Yan, H. "Isocitrate dehydrogenase mutations in gliomas." Neuro-oncology 18, no. 1 (January 2016): 16-26. (Review)  Full Text
    • Boerckel, JD, Chandrasekharan, UM, Waitkus, MS, Tillmaand, EG, Bartlett, R, and Dicorleto, PE. "Mitogen-activated protein kinase phosphatase-1 promotes neovascularization and angiogenic gene expression." Arteriosclerosis, thrombosis, and vascular biology 34, no. 5 (May 2014): 1020-1031.  Full Text
    • Waitkus, MS, Chandrasekharan, UM, Willard, B, Tee, TL, Hsieh, JK, Przybycin, CG, Rini, BI, and Dicorleto, PE. "Signal integration and gene induction by a functionally distinct STAT3 phosphoform." Molecular and cellular biology 34, no. 10 (May 2014): 1800-1811.  Full Text
    • Chandrasekharan, UM, Dechert, L, Davidson, UI, Waitkus, M, Mavrakis, L, Lyons, K, Beach, JR, Li, X, Egelhoff, TT, Fox, PL, and DiCorleto, PE. "Release of nonmuscle myosin II from the cytosolic domain of tumor necrosis factor receptor 2 is required for target gene expression." Science signaling 6, no. 284 (July 16, 2013): ra60-.  Full Text
    • Waitkus, MS, Chandrasekharan, UM, Willard, B, Haque, SJ, and DiCorleto, PE. "STAT3-mediated coincidence detection regulates noncanonical immediate early gene induction." The Journal of biological chemistry 288, no. 17 (April 2013): 11988-12003.  Full Text
    • Chandrasekharan, UM, Waitkus, M, Kinney, CM, Walters-Stewart, A, and DiCorleto, PE. "Synergistic induction of mitogen-activated protein kinase phosphatase-1 by thrombin and epidermal growth factor requires vascular endothelial growth factor receptor-2." Arteriosclerosis, thrombosis, and vascular biology 30, no. 10 (October 2010): 1983-1989.  Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.